EFFICACY OF EVEROLIMUS CONVERSION FROM MYCOPHENOLATE MOFETIL FOR GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS

被引:0
|
作者
Futamura, Kenta [1 ]
Okada, Manabu [1 ]
Hiramitsu, Takahisa [1 ]
Tsujita, Makoto [1 ]
Goto, Norihiko [1 ]
Narumi, Syunji [1 ]
Watarai, Yoshihiko [1 ]
机构
[1] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
BOS100
引用
收藏
页码:194 / 194
页数:1
相关论文
共 50 条
  • [1] EFFICACY OF EVEROLIMUS CONVERSION FROM MYCOPHENOLATE MOFETIL FOR GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS
    Futamura, Kenta
    Minami, Masato
    Tsujita, Makoto
    Goto, Norihiko
    Okada, Manabu
    Hiramitsu, Takahisa
    Narumi, Shunji
    Watarai, Yoshihiko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 1605 - 1605
  • [2] The Use of Letermovir for Ganciclovir-Resistant Cytomegalovirus in Kidney Transplant Recipients
    Basic-Jukic, Nikolina
    Atic, Armin
    TURKISH JOURNAL OF NEPHROLOGY, 2022, 31 (03): : 257 - 260
  • [3] Ganciclovir-resistant cytomegalovirus in organ transplant recipients
    Limaye, AP
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 866 - 872
  • [4] Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients
    Bhorade, SM
    Lurain, NS
    Jordan, A
    Leischner, J
    Villanueva, J
    Durazo, R
    Creech, S
    Vigneswaran, WT
    Garrity, ER
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (12): : 1274 - 1282
  • [5] Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
    Wojciechowski, D.
    Chandran, S.
    Webber, A.
    Hirose, R.
    Vincenti, F.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1773 - 1778
  • [6] LEFLUNOMIDE: A NOVEL THERAPEUTIC AGENT FOR GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS IN KIDNEY TRANSPLANT RECIPIENTS
    Shahira, Eram
    Thomas, Beje
    Talwar, Manish
    Salazar, Maria
    Saigusa, Takamitsu
    Kuppachi, Sarat
    Egidi, M. Francesca
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A87 - A87
  • [7] Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients
    Myhre, Hans-Arne
    Dorenberg, Dagny Haug
    Kristiansen, Knut Ivan
    Rollag, Halvor
    Leivestad, Torbjorn
    Asberg, Anders
    Hartmann, Anders
    TRANSPLANTATION, 2011, 92 (02) : 217 - 223
  • [8] Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors
    Sabe, N.
    Gonzalez-Costello, J.
    Rama, I.
    Niubo, J.
    Bodro, M.
    Roca, J.
    Cruzado, J. M.
    Manito, N.
    Carratala, J.
    TRANSPLANT INTERNATIONAL, 2012, 25 (07) : e78 - e82
  • [9] Use of Maribavir and Letermovir for Ganciclovir-Resistant Cytomegalovirus Infection in Lung Transplant Recipients
    Underwood, H. M.
    Cordry, A.
    Baz, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S513 - S513
  • [10] Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
    Avery, Robin K.
    Arav-Boger, Ravit
    Marr, Kieren A.
    Kraus, Edward
    Shoham, Shmuel
    Lees, Laura
    Trollinger, Brandon
    Shah, Pali
    Ambinder, Rich
    Neofytos, Dionysios
    Ostrander, Darin
    Forman, Michael
    Valsamakis, Alexandra
    TRANSPLANTATION, 2016, 100 (10) : E74 - E80